The First CRISPR Studies for Inherited Disease Will Start Soon – MIT Technology Review
MIT Technology Review |
The First CRISPR Studies for Inherited Disease Will Start Soon
MIT Technology Review Biotech companies have been telling us for a while now that CRISPR, the gene-editing technology, can be shaped into a radically precise form of gene therapy—now one of them, CRISPR Therapeutics, says it's ready to test the idea on people. The startup … CRISPR Therapeutics Submits First Clinical Trial Application for a … Analyzing Arena Pharmaceuticals (ARNA) and Intellia Therapeutics (NTLA) The Analysts Set Intellia Therapeutics Inc (NTLA) PT at $26.00 |
